{"id":214974,"date":"2018-05-10T11:00:04","date_gmt":"2018-05-10T11:00:04","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=214974"},"modified":"2018-05-10T11:00:04","modified_gmt":"2018-05-10T11:00:04","slug":"sepsis-diagnostics-market-segmentation-application-analysis-and-market-forecast-2025-credence-research","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/sepsis-diagnostics-market-segmentation-application-analysis-and-market-forecast-2025-credence-research_214974.html","title":{"rendered":"Sepsis Diagnostics Market Segmentation, Application Analysis and Market Forecast 2025 – Credence Research"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Credence Research Logo”<\/div>\n<\/div>\n<\/div>\n
Early and accurate diagnosis of sepsis is an important step towards correct identification of sepsis causing pathogen. Despite improving outcomes in healthcare, death related to sepsis remains high due to antimicrobial resistance and lack of treatment for causative pathogen.<\/div>\n

According to the latest market report published by Credence Research, Inc. “Sepsis Diagnostics  Market<\/a><\/strong>– Growth, Future Prospects and Competitive Analysis, 2017 – 2025” the global sepsis diagnostics market was valued at US$ 381.8 Bn in 2016, and is expected to reach US$ 764.2 Bn by 2025, expanding at a CAGR of 7.6% from 2017 to 2025.<\/p>\n

Browse the full report Sepsis Diagnostics Market<\/strong> – Growth, Future Prospects and Competitive Analysis, 2017 – 2025 report at http:\/\/www.credenceresearch.com\/report\/sepsis-diagnostics-market<\/a><\/strong><\/p>\n

Market Insights<\/strong><\/p>\n

Early and accurate diagnosis of sepsis is an important step towards correct identification of sepsis causing pathogen. Despite improving outcomes in healthcare, death related to sepsis remains high due to antimicrobial resistance and lack of treatment for causative pathogen. The global sepsis diagnostics market is segmented on the basis of technology type such as molecular diagnostics, microbiology, immunoassays and flow cytometry. In the recent times, sepsis diagnosis with molecular diagnostics is emerging in market and is anticipated to grow significantly over the forecast period due to its higher sensitivity, specificity and lower turn-around time.<\/p>\n

Based on geographical demarcation of the globe, the sepsis diagnostics market is studied for North America (comprising United States and Canada), Europe (studied for United Kingdom, Germany and Rest of Europe), Asia Pacific (cumulative to China, Japan and Rest of Asia Pacific), Latin America (including Brazil, Mexico and Rest of Latin America), and Middle East and Africa (GCC and Rest of Europe). Market size and forecast is also presented for each regional and country-level market for the considered analysis period.<\/p>\n

\"Sepsis<\/p>\n

This report also analyzes the global market with the perspective of currently prevalent drivers and restraining factors. Future opportunities to be harnessed are also discussed in this study.<\/p>\n

Download sample research report @ <\/strong>http:\/\/www.credenceresearch.com\/sample-request\/58913<\/a><\/p>\n

Table Of Content:<\/strong><\/p>\n

Chapter 1. Preface<\/strong>
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted<\/p>\n

Chapter 2. Executive Summary<\/strong>
2.1. Global Sepsis Diagnostics Market Portraiture
2.1.1. Global Sepsis Diagnostics Market, by Product, 2016
2.1.2. Global Sepsis Diagnostics Market, by Technology, 2016
2.1.3. Global Sepsis Diagnostics Market, by Geography, 2016<\/p>\n

Chapter 3. Sepsis Diagnostics: Market Dynamics and Outlook<\/strong>
3.1. Market Definition and Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Competitive Landscape …<\/p>\n

Chapter 7. Company Profiles<\/strong>
7.1. Abbott Laboratories, Inc. 
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Becton, Dickinson and Company 
7.3. Biomerieux, Inc.
7.4. Bruker Corporation
7.5. Cepheid, Inc. 
7.6. Immunexpress, Inc. …<\/p>\n

Request for customization research report @ <\/strong>http:\/\/www.credenceresearch.com\/request-for-customization\/58913<\/a><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Credence Research, Inc
Contact Person:<\/strong> Chris Smith, Global Sales Manager
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1-800-361-8290
Address:<\/strong>105 N 1st ST #429, SAN JOSE, CA 95103 US
City:<\/strong> SAN JOSE
State:<\/strong> California
Country:<\/strong> United States
Website:<\/strong> http:\/\/www.credenceresearch.com\/report\/sepsis-diagnostics-market<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Credence Research Logo” Early and accurate diagnosis of sepsis is an important step towards correct identification of sepsis causing pathogen. Despite improving outcomes in healthcare, death related to sepsis remains high due to antimicrobial resistance and lack of treatment for … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-214974","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/214974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=214974"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/214974\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=214974"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=214974"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=214974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}